SIRACUSA
LIVE

Serial Number

87886335

Owner

IPSEN BIOPHARM LIMITED

Attorney

Frances M. Jagla

Filing Date

Apr 20, 2018

Add to watchlist:

No watchlists yet
View on USPTO

SIRACUSA Trademark

Serial Number: 87886335 • Registration: 6004952

SIRACUSA is a trademark filed by IPSEN BIOPHARM LIMITED on April 20, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

IPSEN BIOPHARM LIMITED (57 trademarks)

ASH ROAD
WREXHAM LL13 9UF , GB

Entity Type: 03

Trademark Details

Filing Date

April 20, 2018

Registration Date

March 10, 2020

Published for Opposition

December 24, 2019

Goods & Services

Pharmaceutical preparations for use in oncology, endocrinology, neurology, hematology, gastroenterology, and for cardiovascular and cognitive disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders, muscle disorders orthopedic disorders, disorders relating to age; pharmaceutical preparations for the treatment of pain, muscle spasm, hemifacial spasm and blepharospasm; pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity; pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other derivatives for use in the treatment of excessive sweating, neuromuscular disorders, muscle disorders, orthopedic disorders, disorders relating to age, pain, muscle spasm, hemifacial spasm and blepharospasm, cervical dystonia, torticollis, cerebral palsy, and spasticity, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin

Conducting clinical trials for others for pharmaceuticals; research in the field of pharmaceuticals; scientific research for the purpose of medical evaluations; biological, clinical and medical research; conducting clinical trials for others; providing information in medical and scientific research in the field of pharmaceutical products and clinical trials; conducting tests on pharmaceuticals

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 10, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 4, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 5, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 5, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 5, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 15, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 15, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 15, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2019 CRFA
ASSIGNED TO LIE
Feb 19, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 13, 2018 GNRN
NON-FINAL ACTION E-MAILED
Aug 13, 2018 GNRT
NON-FINAL ACTION WRITTEN
Aug 13, 2018 CNRT
ASSIGNED TO EXAMINER
Aug 10, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2018 NWOS
NEW APPLICATION ENTERED
Apr 24, 2018 NWAP